T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOXX
2676
DELISTED
VOXX International Corporation Class A
VOXX
| $123K | ﹤0.01% |
11,427
-2,700
| -19% | -$26.8K |
|
|
VTNR
2677
DELISTED
Vertex Energy, Inc
VTNR
| $123K | ﹤0.01% |
36,276
+7,230
| +25% | +$28.4K |
|
2678
Alpha Pro Tech
APT
$55.3M
| $122K | ﹤0.01% |
22,900
| – | – |
|
2679
Mission Produce
AVO
$1.15B
| $122K | ﹤0.01% |
12,062
+1,183
| +11% | +$11K |
|
2680
Veritone
VERI
$137M
| $121K | ﹤0.01% |
66,532
+12,400
| +23% | +$27.6K |
|
2681
Costamare
CMRE
$1.75B
| $120K | ﹤0.01% |
11,458
| – | – |
|
2682
Caribou Biosciences
CRBU
$167M
| $120K | ﹤0.01% |
20,835
+4,637
| +29% | +$22.9K |
|
2683
Definitive Healthcare
DH
$67.3M
| $120K | ﹤0.01% |
12,004
+1,332
| +12% | +$10.5K |
|
|
TERN
2684
DELISTED
Terns Pharmaceuticals
TERN
| $120K | ﹤0.01% |
18,433
+647
| +4% | +$3.42K |
|
2685
GeneDx Holdings
WGS
$2.41B
| $120K | ﹤0.01% |
43,299
| – | – |
|
2686
GrowGeneration
GRWG
$107M
| $118K | ﹤0.01% |
46,835
+1,673
| +4% | +$4.09K |
|
2687
Innodata
INOD
$1.97B
| $117K | ﹤0.01% |
14,366
+407
| +3% | +$3.22K |
|
2688
Teekay
TK
$1.07B
| $115K | ﹤0.01% |
16,067
+376
| +2% | +$2.6K |
|
2689
Aclaris Therapeutics
ACRS
$871M
| $114K | ﹤0.01% |
108,515
-21,372
| -16% | -$65.2K |
|
|
GLDD
2690
DELISTED
Great Lakes Dredge & Dock
GLDD
| $114K | ﹤0.01% |
14,802
| – | – |
|
2691
Tango Therapeutics
TNGX
$4.37B
| $113K | ﹤0.01% |
11,345
+1,129
| +11% | +$9.8K |
|
|
TSVT
2692
DELISTED
2seventy bio
TSVT
| $112K | ﹤0.01% |
26,036
+1,482
| +6% | +$4.55K |
|
|
RPC
2693
Ridgepost Capital
RPC
$980M
| $111K | ﹤0.01% |
+10,861
| New | +$107K |
|
|
TWKS
2694
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $111K | ﹤0.01% |
23,035
+1,710
| +8% | +$7.02K |
|
2695
Energy Vault
NRGV
$678M
| $110K | ﹤0.01% |
47,003
+2,419
| +5% | +$5.58K |
|
2696
Planet Labs
PL
$8.7B
| $110K | ﹤0.01% |
44,463
+5,078
| +13% | +$12K |
|
2697
SGHC Ltd
SGHC
$6.63B
| $110K | ﹤0.01% |
34,397
+3,112
| +10% | +$10.5K |
|
2698
Quantum-Si Incorporated
QSI
$191M
| $109K | ﹤0.01% |
53,782
+1,737
| +3% | +$2.65K |
|
2699
uniQure
QURE
$3.16B
| $109K | ﹤0.01% |
16,100
| – | – |
|
|
NAPA
2700
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $109K | ﹤0.01% |
+11,046
| New | +$112K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.